RVL Pharmaceuticals plc (RVLPQ)

RVL Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Feb 5, 2026	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Market Capitalization	0	111	90	258	363	407
Market Cap Growth	-99.99%	23.46%	-65.11%	-28.96%	-10.82%	-
Enterprise Value	-	108	113	355	539	691
Last Close Price	0.00	1.12	1.08	4.12	6.99	7.75
PS Ratio	-	2.23	5.14	9.29	1.51	1.54
PB Ratio	0.00	2.17	1.17	2.75	3.16	1.06
P/TBV Ratio	-	-	-	88.34	-	-
P/FCF Ratio	-	-	-	17.58	12.26	12.18
P/OCF Ratio	-	-	-	14.66	10.81	10.84
EV/Sales Ratio	-	2.17	6.47	12.77	2.25	2.62
EV/EBITDA Ratio	-	-	-	-	9.96	8.93
EV/EBIT Ratio	-	-	-	-	176.59	121.62
EV/FCF Ratio	-	-	-	24.17	18.21	20.69
Debt / Equity Ratio	3.56	1.13	0.62	2.36	2.38	0.70
Debt / EBITDA Ratio	-	-	-	-	4.83	3.48
Debt / FCF Ratio	-	-	-	15.11	9.23	8.05
Asset Turnover	0.35	0.36	0.07	0.07	0.38	0.31
Inventory Turnover	6.93	8.21	2.34	0.28	4.89	6.78
Quick Ratio	0.31	2.41	2.12	2.10	1.84	1.12
Current Ratio	0.38	2.89	2.95	3.10	2.27	1.51
Return on Equity (ROE)	-182.44%	-80.88%	-97.13%	-85.36%	-108.67%	-26.76%
Return on Assets (ROA)	-23.65%	-18.29%	-18.26%	-9.25%	0.30%	0.41%
Return on Capital Employed (ROCE)	-233.80%	-36.80%	-60.50%	-19.60%	0.80%	0.80%
Earnings Yield	-61500900.90%	-46.55%	-72.17%	-30.87%	-74.64%	-26.95%
FCF Yield	-42779279.28%	-34.72%	-62.83%	5.69%	8.16%	8.21%
Buyback Yield / Dilution	-25.64%	-33.32%	-11.05%	-15.82%	-15.66%	-5.65%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.